Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'.

PMID: 29161364
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Mar 1;29(3):774-775. doi: 10.1093/annonc/mdx747.
Impact factor: 13.926
Publication type: Letter or abstract
Authors: Cherny, N I, Dafni, U, Latino, N J, Pentheroudakis, G, Douillard, J-Y, Tabernero, J, Zielinski, C, Piccart, M J, de Vries, E G E, Bogaerts, J et al.
DOI: 10.1093/annonc/mdx747

Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'.

PMID: 29161364
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Mar 1;29(3):774-775. doi: 10.1093/annonc/mdx747.
Impact factor:
Publication type: Letter or abstract
Authors: Bogaerts, J; Cherny, N I; Dafni, U; de Vries, E G E; Douillard, J-Y; Latino, N J; Pentheroudakis, G; Piccart, M J; Tabernero, J; Zielinski, C et al.
DOI: 10.1093/annonc/mdx747

Reply to the letter to the editor 'Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?' by Del Paggio.

PMID: 29045537
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Feb 1;29(2):521-522. doi: 10.1093/annonc/mdx649.
Impact factor: 13.926
Publication type: Letter or abstract
Authors: Cherny, N I, Dafni, U, Bogaerts, J, Latino, N J, Pentheroudakis, G, Douillard, J-Y, Zielinski, C, Piccart, M J, de Vries, E G E, Tabernero, J et al.
DOI: 10.1093/annonc/mdx649

Reply to the letter to the editor 'Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?' by Del Paggio.

PMID: 29045537
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Feb 1;29(2):521-522. doi: 10.1093/annonc/mdx649.
Impact factor:
Publication type: Letter or abstract
Authors: Bogaerts, J; Cherny, N I; Dafni, U; de Vries, E G E; Douillard, J-Y; Latino, N J; Pentheroudakis, G; Piccart, M J; Tabernero, J; Zielinski, C et al.
DOI: 10.1093/annonc/mdx649

Report on the status of women occupying leadership roles in oncology.

PMID: 30273418
Journal: ESMO open
Year: 2018
Reference: ESMO Open. 2018 Sep 21;3(6):e000423. doi: 10.1136/esmoopen-2018-000423. eCollection 2018.
Impact factor: 0
Publication type: Paper in international publication
Authors: Hofstadter-Thalmann, Eva, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Banerjee, Susana, Curigliano, Giuseppe M.D, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Robert, Caroline et al.
DOI: 10.1136/esmoopen-2018-000423

Report on the status of women occupying leadership roles in oncology.

PMID: 30273418
Journal: ESMO open
Year: 2018
Reference: ESMO Open. 2018 Sep 21;3(6):e000423. doi: 10.1136/esmoopen-2018-000423. eCollection 2018.
Impact factor:
Publication type: Paper in international publication
Authors: Allen, Tamara; Arnold, Dirk; Banerjee, Susana; Curigliano, Giuseppe M.D; Dafni, Urania; Garassino, Marina Chiara; Garralda, Elena; Haanen, John; Hofstadter-Thalmann, Eva; Peters, Solange et al.
DOI: 10.1136/esmoopen-2018-000423

Reporting suspected adverse reactions to new commercialized medicines in real world.

PMID: 29359623
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 May;24(6):816-817. doi: 10.1177/1352458518754999. Epub 2018 Jan 23.
Impact factor: 5.28
Publication type: Paper in international publication
Authors: Agusti Escasany, Antonia et al.
DOI: 10.1177/1352458518754999

Reporting suspected adverse reactions to new commercialized medicines in real world.

PMID: 29359623
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 May;24(6):816-817. doi: 10.1177/1352458518754999. Epub 2018 Jan 23.
Impact factor:
Publication type: Paper in international publication
Authors: Agusti Escasany, Antonia et al.
DOI: 10.1177/1352458518754999

Resistance of high fitness hepatitis C virus to lethal mutagenesis.

PMID: 30107298
Journal: VIROLOGY
Year: 2018
Reference: Virology. 2018 Oct;523:100-109. doi: 10.1016/j.virol.2018.07.030. Epub 2018 Aug 11.
Impact factor: 3.374
Publication type: Paper in international publication
Authors: Gallego, Isabel, Gregori, Josep, Soria, Maria Eugenia, Garcia-Crespo, Carlos, Garcia-Alvarez, Monica, Gomez-Gonzalez, Alfonso, Valiergue, Rosalie, Gomez, Jordi, Esteban, Juan Ignacio, Quer, Josep et al.
DOI: 10.1016/j.virol.2018.07.030

Resistance of high fitness hepatitis C virus to lethal mutagenesis.

PMID: 30107298
Journal: VIROLOGY
Year: 2018
Reference: Virology. 2018 Oct;523:100-109. doi: 10.1016/j.virol.2018.07.030. Epub 2018 Aug 11.
Impact factor:
Publication type: Paper in international publication
Authors: Domingo, Esteban; Esteban, Juan Ignacio; Gallego, Isabel; Garcia-Alvarez, Monica; Garcia-Crespo, Carlos; Gomez, Jordi; Gomez-Gonzalez, Alfonso; Gregori, Josep; Perales, Celia; Quer, Josep et al.
DOI: 10.1016/j.virol.2018.07.030

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.

PMID: 29785104
Journal: International Journal of Chronic Obstructive Pulmonary Disease
Year: 2018
Reference: Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.
Impact factor: 2.917
Publication type: Paper in international publication
Authors: Wehrmeister, Fernando C, Casas, Alejandro, Montes de Oca, Maria, Menezes, Ana Mb, Ramirez, Larissa, Miravitlles, Marc, Mendoza, Laura, Lopez Varela, Maria Victorina et al.
DOI: 10.2147/COPD.S154097

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.

PMID: 29785104
Journal: International Journal of Chronic Obstructive Pulmonary Disease
Year: 2018
Reference: Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.
Impact factor:
Publication type: Paper in international publication
Authors: Casas, Alejandro; Lopez Varela, Maria Victorina; Mendoza, Laura; Menezes, Ana Mb; Miravitlles, Marc; Montes de Oca, Maria; Ramirez, Larissa; Wehrmeister, Fernando C et al.
DOI: 10.2147/COPD.S154097

Respiratory support therapy after extubation: Who and how?

PMID: 29122291
Journal: Medicina Intensiva
Year: 2018
Reference: Med Intensiva. 2018 May;42(4):255-257. doi: 10.1016/j.medin.2017.09.005. Epub 2017 Nov 6.
Impact factor: 1.755
Publication type: Review in international publication
Authors: Hernandez, G, Roca, O et al.
DOI: 10.1016/j.medin.2017.09.005

Respiratory support therapy after extubation: Who and how?

PMID: 29122291
Journal: Medicina Intensiva
Year: 2018
Reference: Med Intensiva. 2018 May;42(4):255-257. doi: 10.1016/j.medin.2017.09.005. Epub 2017 Nov 6.
Impact factor:
Publication type: Review in international publication
Authors: Hernandez, G; Roca, O et al.
DOI: 10.1016/j.medin.2017.09.005

RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371383
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702052. doi: 10.1183/13993003.02052-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Wilson, Robert, Winthrop, Kevin L, Polverino, Eva, De Soyza, Anthony, Aksamit, Timothy, Bandel, Tiemo-Joerg, Criollo, Margarita, Elborn, J Stuart, Operschall, Elisabeth, Roth, Katrin et al.
DOI: 10.1183/13993003.02052-2017

RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371383
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702052. doi: 10.1183/13993003.02052-2017. Print 2018 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Aksamit, Timothy; Bandel, Tiemo-Joerg; Criollo, Margarita; De Soyza, Anthony; Elborn, J Stuart; Operschall, Elisabeth; Polverino, Eva; Roth, Katrin; Wilson, Robert; Winthrop, Kevin L et al.
DOI: 10.1183/13993003.02052-2017

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371384
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702053. doi: 10.1183/13993003.02053-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Aksamit, Timothy, De Soyza, Anthony, Bandel, Tiemo-Joerg, Criollo, Margarita, Elborn, J Stuart, Operschall, Elisabeth, Polverino, Eva, Roth, Katrin, Winthrop, Kevin L, Wilson, Robert et al.
DOI: 10.1183/13993003.02053-2017

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371384
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702053. doi: 10.1183/13993003.02053-2017. Print 2018 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Aksamit, Timothy; Bandel, Tiemo-Joerg; Criollo, Margarita; De Soyza, Anthony; Elborn, J Stuart; Operschall, Elisabeth; Polverino, Eva; Roth, Katrin; Wilson, Robert; Winthrop, Kevin L et al.
DOI: 10.1183/13993003.02053-2017

Response to ECG, March 2018.

PMID: 29587995
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2018
Reference: Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):295. doi: 10.1016/j.rec.2017.09.019.
Impact factor: 5.166
Publication type: Letter or abstract
Authors: Figueras-Coll, Marc, Rivas-Gandara, Nuria, Roses-Noguer, Ferran et al.
DOI: 10.1016/j.rec.2017.09.019

Response to ECG, March 2018.

PMID: 29587995
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2018
Reference: Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):295. doi: 10.1016/j.rec.2017.09.019.
Impact factor:
Publication type: Letter or abstract
Authors: Figueras-Coll, Marc; Rivas-Gandara, Nuria; Roses-Noguer, Ferran et al.
DOI: 10.1016/j.rec.2017.09.019

Response to Letter to the Editor.

PMID: 30086556
Journal: NEUROPEDIATRICS
Year: 2018
Reference: Neuropediatrics. 2018 Oct;49(5):355. doi: 10.1055/s-0038-1667354. Epub 2018 Aug 7.
Impact factor: 1.605
Publication type: Letter or abstract
Authors: Macaya, Alfons, Boronat, Susana et al.
DOI: 10.1055/s-0038-1667354

Response to Letter to the Editor.

PMID: 30086556
Journal: NEUROPEDIATRICS
Year: 2018
Reference: Neuropediatrics. 2018 Oct;49(5):355. doi: 10.1055/s-0038-1667354. Epub 2018 Aug 7.
Impact factor:
Publication type: Letter or abstract
Authors: Boronat, Susana; Macaya, Alfons et al.
DOI: 10.1055/s-0038-1667354

Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study.

PMID: 29233512
Journal: Endocrinologia, diabetes y nutricion
Year: 2018
Reference: Endocrinol Diabetes Nutr. 2018 Jan;65(1):17-20. doi: 10.1016/j.endinu.2017.10.007. Epub 2017 Dec 7.
Impact factor: 0
Publication type: Paper in national publication
Authors: Simo, Rafael, Mesa, Jordi, Hernandez, Cristina, Vilallonga, Ramon, Balibrea, Jose Maria, Simo-Servat, Olga, Ciudin, Andreea et al.
DOI: 10.1016/j.endinu.2017.10.007

Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study.

PMID: 29233512
Journal: Endocrinologia, diabetes y nutricion
Year: 2018
Reference: Endocrinol Diabetes Nutr. 2018 Jan;65(1):17-20. doi: 10.1016/j.endinu.2017.10.007. Epub 2017 Dec 7.
Impact factor:
Publication type: Paper in national publication
Authors: Balibrea, Jose Maria; Ciudin, Andreea; Hernandez, Cristina; Mesa, Jordi; Simo, Rafael; Simo-Servat, Olga; Vilallonga, Ramon et al.
DOI: 10.1016/j.endinu.2017.10.007